News | June 01, 2021
Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
The GMP certificate is valid for three years until April 2024.
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
The commercial production in the SML was started in November 1989.
Delivers robust earnings performance, successfully navigating a dynamic environment
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Raichur site is the group’s largest API facility and part of a wider network of seven sites
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Subscribe To Our Newsletter & Stay Updated
